| Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator. | ovarian, |
| investigation of role of bFGF in invasiveness of ovarian cancer: bFGF regulates gene expression (up-regulation) of urokinase-type plasminogen activator & proto-oncogene c-ets-1; proto-oncogene c-ets-1 is additional regulatory factor | ovarian, |
| Interleukin-1 induces rapid and transient expression of the c-fos proto-oncogene in isolated pancreatic islets and in purified beta-cells. | pancreatic, |
| [The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer]. | prostate, |
| miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer | breast, |
| miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. | breast, |
| Elevated expression of ETS-1 gene in a metastatic, tumorigenic human prostate epithelial cell line transformed by the v-Ki-ras oncogene. | prostate, |
| Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder. | bladder, |
| Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. | sarcoma, |
| Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma. | skin, |
| Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction. | breast, |
| ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma. | laryngeal, |
| Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells. | prostate, |
| The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. | leukemia, |
| These data suggest a role for oncogenic ETS1 transcriptional activity in promoting aggressive prostate cancer and the castrate-resistant phenotype. | prostate, |
| Control of MicroRNA-21 expression in colorectal cancer cells by oncogenic epidermal growth factor/Ras signaling and Ets transcription factors. | colorectal, |
| Transposition of the oncogene ets-1 in t(11;19) translocation in acute leukemia. | leukemia, |
| Data suggest that erythroblastosis virus E26 oncogen homolog-1 (ETS-1) is a common mediator of the proinflammatory and profibrotic effects of Ang II-induced hypertensive renal damage. | kidney, |
| Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. | breast, |
| Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer. | breast, |